We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 270.00
Bid: 265.00
Ask: 269.00
Change: -1.00 (-0.37%)
Spread: 4.00 (1.509%)
Open: 266.00
High: 270.00
Low: 261.00
Prev. Close: 271.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Date   Source Headline
14th Jul 20219:35 amRNSHolding(s) in Company
13th Jul 20217:00 amRNSFirst Commercial Sale of ORPATHYS® in China
12th Jul 20212:35 pmRNSFull Exercise of the Over-allotment Option
6th Jul 20219:30 amRNSHUTCHMED Initiates Phase I Trials of HMPL-295
2nd Jul 202111:15 amRNSHolding(s) in Company
2nd Jul 20219:30 amRNSNotice of Results
1st Jul 202111:00 amRNSUS FDA Accepts NDA Filing for Surufatinib
30th Jun 202110:02 amRNSHoldings in Company
30th Jun 202110:01 amRNSTotal Voting Rights
30th Jun 202110:00 amRNSClosing of Global Offering and Hong Kong Listing
29th Jun 20217:00 amRNSBlocklisting Six Monthly Return
23rd Jun 20213:21 pmRNSHUTCHMED Announces Pricing of Global Offering
22nd Jun 20216:22 pmRNSSavolitinib approved in China for lung cancer
18th Jun 20214:05 pmRNSHUTCHMED Announces NMPA Approval of Surufatinib
18th Jun 20217:01 amRNSHUTCHMED Launches Hong Kong IPO
18th Jun 20217:00 amRNSDisclosure Update
20th May 20217:00 amRNSClinical Data to be Presented at ASCO21
17th May 20217:00 amRNSHUTCHMED to Host Company Update
7th May 202112:00 pmRNSHUTCHMED to Attend Upcoming Investor Conferences
4th May 20218:00 amRNSChange of Company Name
4th May 20217:00 amRNSSurufatinib FDA Rolling NDA Submission Completed
30th Apr 20214:41 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
29th Apr 20217:00 amRNSPhase II Registration Study of HMPL-689 Initiated
28th Apr 20212:20 pmRNSResult of AGM
23rd Apr 20217:00 amRNSVesting of awards under Long Term Incentive Plan
14th Apr 202110:30 amRNSNotification of Dilution of Voting Rights
8th Apr 20218:30 amRNS$100m Investment by Baring Private Equity Asia
31st Mar 20217:00 amRNSTotal Voting Rights
29th Mar 20219:30 amRNSGrant of LTIP Awards and Share Options
29th Mar 20217:00 amRNSInitiates International Phase I Trials of HMPL-306
26th Mar 20217:00 amRNSAnnual Financial Report
24th Mar 20211:30 pmRNSAgreement to Divest Non-Core OTC Joint Venture
24th Mar 20217:00 amRNSPhase Ib/II Trial of Surufatinib with Tislelizumab
10th Mar 20217:00 amRNSVesting of awards under Long Term Incentive Plan
4th Mar 20213:15 pmRNSPublication of Form 20-F
4th Mar 202112:00 pmRNSFinal Results, Business Update and Name Change
3rd Feb 20217:00 amRNSNotice of Results
14th Jan 202110:00 amRNSSavolitinib Data to be Presented at Virtual WCLC
11th Jan 20217:00 amRNSChi-Med & Inmagene Announce Strategic Partnership
31st Dec 20207:00 amRNSBlocklisting Six Monthly Return
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 202012:00 pmRNSNMPA approval of Surufatinib in China for ep-NET
29th Dec 20207:45 amRNSUS NDA Rolling Submission of Surufatinib Initiated
22nd Dec 20207:00 amRNSChi-Med to Present at JPM
15th Dec 20209:45 amRNSGrant of Share Options under Share Option Scheme
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSNotification of Dilution of Voting Rights
17th Nov 20207:00 amRNSUS$100m Equity Investment by CPP Investments
5th Nov 20209:00 amRNSChi-Med to Present HMPL-689 Clinical Data at ASH

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.